These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 227236)

  • 1. Line cell saga - an argument in favor of production of biologics in cancer cells.
    Hilleman MR
    Adv Exp Med Biol; 1979; 118():47-58. PubMed ID: 227236
    [No Abstract]   [Full Text] [Related]  

  • 2. Choice of cell substrate for biological products.
    Beale AJ
    Adv Exp Med Biol; 1979; 118():83-97. PubMed ID: 227238
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of diploid cell lines as a multiplication substrate for viral vaccine production].
    Welke G
    Z Gesamte Hyg; 1980; 26(5):365-72. PubMed ID: 7008390
    [No Abstract]   [Full Text] [Related]  

  • 4. New trends in the preparation of cell substrates for the production of virus vaccines.
    van Wezel AL
    Prog Immunobiol Stand; 1971; 5():187-92. PubMed ID: 4349819
    [No Abstract]   [Full Text] [Related]  

  • 5. Newer directions in vaccine development and utilization.
    Hilleman MR
    J Infect Dis; 1985 Mar; 151(3):407-19. PubMed ID: 2982958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postvaccinal antiviral immunity and the role of tissue protective reactions in its mechanisms].
    Gorshunova LP
    Vestn Akad Med Nauk SSSR; 1972; 27(6):77-83. PubMed ID: 4345217
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospects for a rubella virus vaccine.
    Parkman PD; Meyer HM
    Prog Med Virol; 1969; 11():80-106. PubMed ID: 4984711
    [No Abstract]   [Full Text] [Related]  

  • 8. [Present issues in antiviral vaccines (author's tranls)].
    Pauluzzi S
    Ann Sclavo; 1979; 21(6):823-35. PubMed ID: 554552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cancer virus vaccines and the pursuit of the practical.
    Hilleman MR
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1439-45. PubMed ID: 4371268
    [No Abstract]   [Full Text] [Related]  

  • 10. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 11. PER.C6(®) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine.
    Sanders BP; Edo-Matas D; Custers JH; Koldijk MH; Klaren V; Turk M; Luitjens A; Bakker WA; Uytdehaag F; Goudsmit J; Lewis JA; Schuitemaker H
    Vaccine; 2013 Jan; 31(5):850-6. PubMed ID: 23123018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary results on the use of human diploid fibroblasts for inactivated polio virus vaccine production.
    Larsson B; Litwin J
    Dev Biol Stand; 1980; 46():241-7. PubMed ID: 6245000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Design of inactivated polyvalent antiherpes vaccines].
    Andonov P; Dundarov S; Bakalov B
    Vopr Virusol; 1979; (6):665-71. PubMed ID: 230648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINE. III. IS THERE INTERFERENCE BY SV 40 AGAINST POLIOVIRUS?].
    GUENTHER O; VON METTENHEIM ; HOEVEL H
    Zentralbl Bakteriol Orig; 1964 Feb; 192():1-11. PubMed ID: 14176847
    [No Abstract]   [Full Text] [Related]  

  • 15. Controlled trial of immune response of preterm infants to recombinant hepatitis B and inactivated poliovirus vaccines administered simultaneously shortly after birth.
    Linder N; Handsher R; German B; Sirota L; Bachman M; Zinger S; Mendelson E; Barzilai A
    Arch Dis Child Fetal Neonatal Ed; 2000 Jul; 83(1):F24-7. PubMed ID: 10873167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell substrate for killed poliovaccine production.
    Beale AJ
    Dev Biol Stand; 1981; 47():19-23. PubMed ID: 6262147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relations in interferon production and other known properties between CAL 11914 and TCND strains of Newcastle disease virus.
    Bankowski RA; Kaleta EF
    Avian Dis; 1972; 16(3):481-91. PubMed ID: 5038647
    [No Abstract]   [Full Text] [Related]  

  • 18. Tissue culture of viruses (author's transl).
    Can J Med Technol; 1974 Jun; 36(3):231 passim. PubMed ID: 4368290
    [No Abstract]   [Full Text] [Related]  

  • 19. Viral vaccines and residual cellular DNA.
    Horaud F
    Biologicals; 1995 Sep; 23(3):225-8. PubMed ID: 8527122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of enhanced plaque formation by poliovirus in poxvirus-infected cells.
    Tsuchiya Y; Tagaya I
    J Gen Virol; 1972 Mar; 14(3):237-42. PubMed ID: 4336519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.